Formosa Laboratories, Inc. (TPE:4746)
57.40
-0.70 (-1.20%)
Jan 22, 2026, 11:40 AM CST
Formosa Laboratories Revenue
Formosa Laboratories had revenue of 1.16B TWD in the quarter ending September 30, 2025, with 12.59% growth. This brings the company's revenue in the last twelve months to 4.90B, up 6.68% year-over-year. In the year 2024, Formosa Laboratories had annual revenue of 4.73B with 8.50% growth.
Revenue (ttm)
4.90B
Revenue Growth
+6.68%
P/S Ratio
1.44
Revenue / Employee
17.50M
Employees
280
Market Cap
7.05B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.73B | 370.60M | 8.50% |
| Dec 31, 2023 | 4.36B | 594.94M | 15.80% |
| Dec 31, 2022 | 3.77B | 623.10M | 19.83% |
| Dec 31, 2021 | 3.14B | 66.95M | 2.18% |
| Dec 31, 2020 | 3.08B | 315.87M | 11.45% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| YungShin Global Holding | 8.37B |
| Standard Chemical & Pharmaceutical | 6.91B |
| Synmosa Biopharma | 6.11B |
| Orient EuroPharma | 4.53B |
| Handa Pharmaceuticals | 1.62B |
| Maywufa Company | 1.55B |
| SCI Pharmtech | 1.39B |
| Orient Pharma | 1.28B |